The increased thyroidal expression of BAFF and its primary receptor, BAFF-R, in the infiltrating immune cells and thyrocytes in patients with Graves’ hyperthyroidism suggests a central role of the BAFF–BAFF-R interactions in its pathogenesis (77). Here, TNFSF13B is linked to Graves disease.